title: [The use of piribedil for the prevention of falls in elderly patients with metabolic syndrome].
abstract: Effects of pirebedil used to prevent falls in elderly patients with metabolic syndrome are discussed. A prospective controlled study showed that therapy with pirebedil significantly decreases the frequency of falls, reduces severity of pro-inflammatory and pro-oxidative activities, improves cognitive abilities. Prevention of falls by virtue of improved cognitive abilities is a new clinical effect of pirebedil and gives reason to recommend it for the treatment of geriatric patients with metabolic syndrome.
authors.forename: A N
authors.initials: AN
authors.lastname: Il'nitskiĭ
authors.forename: K I
authors.initials: KI
authors.lastname: Proshchaev
authors.forename: G I
authors.initials: GI
authors.lastname: Shvartsman
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Bakhmutova
authors.forename: N M
authors.initials: NM
authors.lastname: Pozdniakova
authors.forename: V V
authors.initials: VV
authors.lastname: Krivetskiĭ
authors.forename: L Iu
authors.initials: LIu
authors.lastname: Varavina
mesh_terms: D000058:Accidental Falls / Q000517:prevention & control*; D000368:Aged; D001928:Brain Diseases, Metabolic / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000523:psychology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics; D005260:Female; D015577:Geriatric Assessment / Q000379:methods; D006801:Humans; D008297:Male; D016743:Mental Competency; D008875:Middle Aged; D018697:Nootropic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D010891:Piribedil / Q000008:administration & dosage / Q000493:pharmacokinetics; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D018491:Dopamine Agonists; D018697:Nootropic Agents; D010891:Piribedil